OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
ORAGENICS INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.42−0.01 (-2.97%)
Close on Oct 19, 2026
- Market cap
- $1.87M
- P/E (TTM)
- –
- Dividend yield
- –
Price history
Daily open, high, low, close and volume
| Date | Open | High | Low | Close | Change | Volume |
|---|---|---|---|---|---|---|
| Daily prices are not in StockData yet. This table fills in once an end-of-day price source is connected. | ||||||
Stock splits
From SEC filings
| Date | Ratio | Effect on per-share figures |
|---|---|---|
| Jun 3, 2025 | 1-for-30 reverse | Earlier per-share figures multiplied by 30 |
| Apr 17, 2023(first seen in filings) | 1-for-58 reverse | Earlier per-share figures multiplied by 58 |
| Jan 23, 2023 | 1-for-60 reverse | Earlier per-share figures multiplied by 60 |
| Jan 22, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Jan 8, 2018 | 1-for-10 reverse | Earlier per-share figures multiplied by 10 |
| Sep 28, 2010 | 1-for-20 reverse | Earlier per-share figures multiplied by 20 |